Target intelligence / Profile preview

Vitamin K-dependent protein S (Protein S)

Target
Protein S
Molecular classification
Other, Glycoprotein, Coagulation factor (not an enzyme, receptor, transporter, or ion channel)
01

Overview

Vitamin K-dependent protein S (also known as Protein S or PROS) is a plasma glycoprotein synthesized in the liver that acts as a critical cofactor for activated protein C in the degradation of coagulation factors Va and VIIIa, thereby exerting a key regulatory effect on blood coagulation and thrombosis prevention. Approximately 60% of circulating protein S is bound to C4b-binding protein (C4BP) and inactive, while 40% remains free and functionally active as a cofactor[4][6]. Beyond coagulation, protein S participates in the clearance of apoptotic cells by bridging phospholipids on the surface of dying cells to phagocytes, facilitating non-inflammatory removal[3][4]. Mutations or deficiencies in protein S (PROS1 gene) confer a high risk for venous thromboembolism and rare, severe inherited thrombophilias. Protein S is not a direct therapeutic drug target (i.e., no drugs selectively modulate or block it), but its levels and function are clinically significant in managing coagulation disorders and monitoring anticoagulant therapy[4][6].

Other names
PROSPROS1Protein SVitamin K-dependent plasma protein S
02

Mechanism of action

Acts as a cofactor for activated protein C to degrade coagulation factors Va and VIIIa; indirectly involved in regulation of coagulation and clearance of apoptotic cells[1][3][4]

03

Biological functions

AnticoagulationApoptosis regulation (via enhancement of phagocytosis of apoptotic cells)Modulation of complement regulation
04

Disease associations

Cardiovascular disease (thrombosis, venous thromboembolism)Rare inherited protein S deficiency disorders
05

Safety considerations

Protein S deficiency leads to increased risk of thrombosis; overcorrection or broad anticoagulation with warfarin can reduce protein S activity contributing to clotting disorders[4]
06

Interacting drugs

None directly approved as drugs that bind or modulate protein S; however, its function is affected by vitamin K antagonists (e.g., warfarin) indirectly[4][6]
07

Biomarkers

Protein S plasma level is used in diagnosing inherited or acquired thrombophilia and monitoring anticoagulant therapy[4]

Beyond the preview

Go deeper on Vitamin K-dependent protein S (Protein S).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitamin K-dependent protein S (Protein S).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call